AYESHA JAMEEL
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TACOMA, WA NPI 1013399856
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism WA Novo Nordisk AS All categories
General Payments — all program years on this page
$7,970.30
- Category: General Payments
- Program years: PY2020–2024
- Record count: 456
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,446.83 across 71 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,446.83 | 71 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $427.64 | 23 |
| Xeris Pharmaceuticals, Inc. | $182.15 | 9 |
| Corcept Therapeutics | $120.28 | 4 |
| Insulet Corporation | $100.90 | 5 |
| ABBVIE INC. | $94.19 | 4 |
| DEXCOM, INC. | $84.97 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $72.79 | 4 |
| Medtronic, Inc. | $48.89 | 3 |
| Amgen Inc. | $43.51 | 2 |
| Tandem Diabetes Care, Inc. | $42.77 | 2 |
| Alexion Pharmaceuticals, Inc. | $40.59 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.85 | 2 |
| Lilly USA, LLC | $23.84 | 1 |
| Amneal Pharmaceuticals LLC | $23.83 | 1 |
| Ultragenyx Pharmaceutical Inc. | $23.82 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.10 | 1 |
| PFIZER INC. | $23.05 | 1 |
| IBSA Pharma Inc. | $21.59 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.07 | 1 |
By program year
Records — PY2024 (71)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.